Rubraca
- Product NDC
- 69660-201
- 11-digit product format
- 696600201
- Labeler code
- 69660
- Product ID
- 69660-201_6377c685-557e-45d5-b860-530973ca8fcc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rucaparib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Clovis Oncology, Inc.
- Application
- NDA209115
- Marketing category
- NDA
- Marketing start
- 2016-12-19
- Marketing end
- 0000-00-00
- Substance
- RUCAPARIB CAMSYLATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69660-201 | RUBRACA (RUCAPARIB) TABLET, FILM COATED [CLOVIS ONCOLOGY, INC.] | 14 | Legacy NDC | 20240223_a6d46c03-bb1d-417b-b8e5-3bffe352fe29.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69660-201-91 | 69660020191 | 60 TABLET, FILM COATED in 1 BOTTLE (69660-201-91) | 2016-12-19 | 0000-00-00 | No | No | Current |